Evidence map›Paper›PMID 33334590›Full record

ArticleRadiologia

Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications.

M L Parra Gordo, G Buitrago Weiland, M Grau García, G Arenaza Choperena

Open access · greenAbstract read
In one paragraph

Article in Radiologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. [Etiology of bacterial pneumonias in patients with COVID-19].Revista medica del Instituto Mexicano del Seguro Social · 2022
    Article
  4. Article
  5. Review
  6. SARS-CoV-2, HIV, andClinical case reports · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. [Mycophenolate as a corticoid saver in a patient with pneumonia organized by COVID-19].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Article
  13. Review
  14. Pneumothorax due to COVID-19: Analysis of case reports.Respiratory medicine case reports · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

M L Parra GordoSección de Radiología de Urgencias, Servicio de Radiodiagnóstico, Hospital Universitario La Paz, Madrid, España. Electronic address: parragm19@gmail.com.
G Buitrago WeilandSección de Radiología Torácica, Servicio de Radiodiagnóstico, Hospital Universitario Gregorio Marañón, Madrid, España.
M Grau GarcíaSección de Radiología de Urgencias, Servicio de Radiodiagnóstico, Hospital Universitario Basurto, Bilbao, España.
G Arenaza ChoperenaSección de Radiología de Urgencias, Servicio de Radiodiagnóstico, Hospital Universitario de Donostia, San Sebastián, España.
Biogipuzkoa Health Research Institute · ESHospital de Basurto · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outcomes vary widely in patients with COVID-19. Whereas some patients have only mild symptoms of short duration, others develop severe disease that leads to acute respiratory distress syndrome requiring prolonged stays in intensive care units. Radiologically, the initial stage is characterized by viral pneumonia with mild expression. In some patients, however, the onset of the immune response results in acute lung damage with organizing pneumonia and diffuse alveolar damage. Moderate-severe disease is associated with a high incidence of pulmonary embolisms, generally peripherally distributed and associated with endothelial damage, prolonged stays in bed, and coagulopathy. Other relatively common complications are spontaneous pneumothorax and pneumomediastinum due to the rupture of alveolar walls and barotrauma in mechanically ventilated patients. Superinfection, generally bacterial and less commonly fungal, is more common in patients with severe disease.

Indexed as

COVID-19HumansPneumonia, ViralSeverity of Illness Indexacute respiratory distress syndromeComplicaciones torácicasCoronavirusCOVID-19Daño alveolar difusodiffuse alveolar damageEmbolia pulmonarNeumomediastinoNeumonía organizadaNeumotóraxorganizing pneumoniapneumomediastinum.pneumothoraxpulmonary embolismSARS-CoV-2Síndrome de distrés respiratorio agudothoracic complicationsthrombosisTrombosis

Identifiers

PMID33334590
PMCPMC7687358
OpenAlexW3109533191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.